Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 8291 | Pages: 175 | July 2018 | Region: Global


Angina Pectoris drugs Market was worth USD xx billion in 2017 and estimated to be growing at a CAGR of xx%, to reach USD xx billion by 2022.Angina pectoris refers to the disorder characterised by chest pain due to insufficient blood flow to the heart. It can also be caused due to anaemia, abnormal heart rhythms and heart failure. It Is classified into stable and unstable angina.

Increased prevalence of cardiovascular diseases and rise in the geriatric population are driving the market growth. Increased research and development projects in the healthcare segment and increased healthcare expenditure are further fuelling the market growth. However, the huge investment which goes into developing new drugs is the major factor hampering the growth of the market.

The market for Angina Pectoris drugs is broadly categorized into therapeutic class. By therapeutic class the market is segmented into beta blockers, calcium antagonists, anticoagulants, anti-platelets and others. On the basis of geography, the market is analysed under various regions namely North America, Europe, Asia-Pacific and Rest of the World. The Angina Pectoris drugs market was dominated by North America, with the overall market share of over 33% globally. North America was followed by Europe and Asia-Pacific. Asia Pacific is predicted to grow at a rapid pace in the coming few years.

Some of the major companies dominating the market, by their products and services include Sanofi, Bayer HealthCare, Cardeus Pharmaceuticals and CardioVascular BioTherapeutics (CVBT), Merck & Co. Inc., Anthera Pharmaceuticals, Cardium Therapeutics, Astellas Pharma, Ark Therapeutics Group plc, Torrent Pharmaceuticals Limited, Circ Pharma Limited, HUYA Bioscience International LLC, Lacer S.A., Viromed Co. Ltd. and Baxter Healthcare Corporation.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Therapeutic class                     

                                5.1.1 Introduction           

                                5.1.2 Beta blockers         

                                5.1.3 Calcium anatagonists          

                                5.1.4 Anticoagulants      

                                5.1.5 Anti platelets         

                                5.1.6 Others      

                                5.1.7  Y-o-Y Growth Analysis, By therapeutic class            

                                5.1.8  Market Attractiveness Analysis, By therapeutic class          

                                5.1.9 Market Share Analysis, By therapeutic class             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By therapeutic class

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By therapeutic class

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By therapeutic class

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Anthera Pharmaceuticals                     

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Cardium Therapeutics                            

                8.3 Sanofi                           

                8.4 Bayer HealthCare                     

                8.5 Cardeus Pharmaceuticals                     

                8.6 Ark Therapeutics Group plc                 

                8.7 Torrent Pharmaceuticals Limited                       

                8.8 Circ Pharma Limited                

                8.9 Viromed Co. Ltd.                      

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Therapeutic Class, By Region along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

TitlePriceAdd To Cart
  1. Global Angina Pectoris drugs Market By Region, From 2018-2023 ( USD Million )
  2. Global Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  3. Global Beta blockers Market By Region, From 2018-2023 ( USD Million )
  4. Global Calcium antagonists Market By Region, From 2018-2023 ( USD Million )
  5. Global Anti coagulants Market By Region, From 2018-2023 ( USD Million )
  6. Global Anti platelets Market By Region, From 2018-2023 ( USD Million )
  7. Global Others Market By Region, From 2018-2023 ( USD Million )
  8. North America Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  9. North America Beta blockers Market By Region, From 2018-2023 ( USD Million )
  10. North America Calcium antagonists Market By Region, From 2018-2023 ( USD Million )
  11. North America Anti coagulants Market By Region, From 2018-2023 ( USD Million )
  12. North America Anti platelets Market By Region, From 2018-2023 ( USD Million )
  13. North America Others Market By Region, From 2018-2023 ( USD Million )
  14. United States Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  15. Canada Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  16. Europe Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  17. Europe Beta blockers Market By Region, From 2018-2023 ( USD Million )
  18. Europe Calcium antagonists Market By Region, From 2018-2023 ( USD Million )
  19. Europe Anti coagulants Market By Region, From 2018-2023 ( USD Million )
  20. Europe Anti platelets Market By Region, From 2018-2023 ( USD Million )
  21. Europe Others Market By Region, From 2018-2023 ( USD Million )
  22. U.K. Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  23. Germany Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  24. France Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  25. Italy Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  26. Spain Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  27. Asia Pacific Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  28. Asia Pacific Beta blockers Market By Region, From 2018-2023 ( USD Million )
  29. Asia Pacific Calcium antagonists Market By Region, From 2018-2023 ( USD Million )
  30. Asia Pacific Anti coagulants Market By Region, From 2018-2023 ( USD Million )
  31. Asia Pacific Anti platelets Market By Region, From 2018-2023 ( USD Million )
  32. Asia Pacific Others Market By Region, From 2018-2023 ( USD Million )
  33. Japan Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  34. China Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  35. India Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  36. Australia Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  37. South Korea Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  38. Latin America Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  39. Latin America Beta blockers Market By Region, From 2018-2023 ( USD Million )
  40. Latin America Calcium antagonists Market By Region, From 2018-2023 ( USD Million )
  41. Latin America Anti coagulants Market By Region, From 2018-2023 ( USD Million )
  42. Latin America Anti platelets Market By Region, From 2018-2023 ( USD Million )
  43. Latin America Others Market By Region, From 2018-2023 ( USD Million )
  44. Brazil Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  45. Argentina Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  46. Mexico Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  47. Rest of Latin America Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  48. Middle East and Africa Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  49. Middle East and Africa Beta blockers Market By Region, From 2018-2023 ( USD Million )
  50. Middle East and Africa Calcium antagonists Market By Region, From 2018-2023 ( USD Million )
  51. Middle East and Africa Anti coagulants Market By Region, From 2018-2023 ( USD Million )
  52. Middle East and Africa Anti platelets Market By Region, From 2018-2023 ( USD Million )
  53. Middle East and Africa Others Market By Region, From 2018-2023 ( USD Million )
  54. Middle East Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
  55. Africa Angina Pectoris drugs Market By Therapeutic class, From 2018-2023 ( USD Million )
Middle East And Africa Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth...
Asia Pacific Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, A...
Europe Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Fo...
North America Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, ...
Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts ...
Middle East And Africa Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) A...
Latin America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Asia Pacific Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Regi...
Europe Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - I...
North America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - Industry...
Pharmaceutical Gelatin Market By Function (stabilizers, Thickeners, Gelling Agents And Others) , By Source( Pig Skin, Bovine Hides, Bones And Others), By Application ( Hard Capsules, Soft Capsules, Microencapsulatio...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.